Adial Pharmaceuticals (ADIL)
(Delayed Data from NSDQ)
$1.70 USD
-0.09 (-5.03%)
Updated May 3, 2024 04:00 PM ET
After-Market: $1.73 +0.03 (1.76%) 7:58 PM ET
4-Sell of 5 4
F Value B Growth A Momentum D VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 5/10/24 |
---|---|
Current Quarter | -0.51 |
EPS Last Quarter | NA |
Last EPS Surprise | NA |
ABR | 1.67 |
Earnings ESP
|
0.00% |
---|---|
Current Year | -1.66 |
Next Year | -12.82 |
EPS (TTM) | -7.97 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | NA | NA | NA | NA |
# of Estimates | NA | NA | NA | NA |
High Estimate | NA | NA | NA | NA |
Low Estimate | NA | NA | NA | NA |
Year ago Sales | 0.00M | 0.00M | NA | NA |
Year over Year Growth Est. | NA | NA | NA | NA |
Earnings Estimates
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.51 | -0.39 | -1.66 | -12.82 |
# of Estimates | 1 | 1 | 1 | 1 |
Most Recent Consensus | -0.51 | -0.39 | -1.66 | -12.82 |
High Estimate | -0.51 | -0.39 | -1.66 | -12.82 |
Low Estimate | -0.51 | -0.39 | -1.66 | -12.82 |
Year ago EPS | -2.75 | -1.33 | -4.91 | -1.66 |
Year over Year Growth Est. | 81.45% | 70.68% | 66.19% | -672.29% |
Agreement - Estimate Revisions
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 0 | 0 |
Up Last 60 Days | 0 | 0 | 0 | 0 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 0 | 0 |
Down Last 60 Days | 1 | 1 | 1 | 0 |
Magnitude - Consensus Estimate Trend
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.51 | -0.39 | -1.66 | -12.82 |
7 Days Ago | -0.51 | -0.39 | -1.66 | -12.82 |
30 Days Ago | -0.51 | -0.39 | -1.66 | -12.82 |
60 Days Ago | -0.37 | -0.37 | -1.46 | -12.82 |
90 Days Ago | -0.37 | -0.37 | -1.46 | -12.82 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.51 | -0.39 | -1.66 | -12.82 |
Zacks Consensus Estimate | -0.51 | -0.39 | -1.66 | -12.82 |
Earnings ESP | 0.00% | 0.00% | 0.00% | 0.00% |
Surprise - Reported Earnings History
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Quarter Ending (3/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | NA | -1.14 | -1.33 | -2.75 | NA |
Estimate | NA | -1.14 | -1.50 | -3.50 | NA |
Difference | NA | 0.00 | 0.17 | 0.75 | 0.31 |
Surprise | NA | 0.00% | 11.33% | 21.43% | 10.92% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more